VitaDAO founders launched the "BIO" protocol in collaboration with the DAO, aiming to raise funds for scientific research
ChainCatcher news, according to CoinDesk, the founder of the decentralized autonomous organization VitaDAO, which aims to fund longevity research projects, has launched a new protocol called BIO. This protocol is designed to enable the global community of patients, scientists, and biotechnology developers to collaboratively fund the development and commercialization of new therapies. The protocol raises funds through a decentralized autonomous organization (DAO), using the proceeds from token sales to support relevant biotechnology projects, thereby facilitating the sharing of intellectual property. BIO raised $6.2 million through a public sale in its initial token generation event (TGE), with participants including venture capital firms such as Zee Prime and 1kx. Details of the second round of TGE will be announced soon.